LINQ II Insertable Cardiac Monitor vs Vivid T9/Vivid T8

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by GE HealthCare

AI Verdict

Tool A is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia diagnosis, leveraging AI for enhanced accuracy. Tool B is an advanced cardiovascular ultrasound system that uses AI to improve real-time imaging, workflow, and diagnostics of cardiac structure and function. While both utilize AI in cardiology, they address distinct diagnostic needs—monitoring versus imaging—making them complementary rather than directly comparable.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring for the diagnosis of infrequent or unexplained arrhythmias that may not be captured by shorter-term external devices. Its AI-powered accuracy and up to 4.5 years of monitoring provide a comprehensive solution for extended diagnostic periods, including remote management capabilities.

View LINQ II Insertable Cardiac Monitor →

Choose Vivid T9/Vivid T8 if…

Choose the Vivid T9/T8 Cardiovascular Ultrasound Systems if your clinical practice demands real-time, high-quality cardiovascular imaging with integrated AI-powered tools to enhance diagnostic accuracy and workflow efficiency during patient exams. These systems are ideal for immediate assessment of cardiac structure and function, offering shared services capabilities for broader imaging needs.

View Vivid T9/Vivid T8 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Vivid T9/Vivid T8
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. Unknown
FDA Status Cleared AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool A, the LINQ II, offers superior usability by focusing on both patient and clinician experience. Its MyCareLink Heartu2122 mobile app and remote programming capabilities significantly reduce the need for in-office visits and streamline data transmission for patients, while the Reveal LINQ Mobile Manager app simplifies device activation and programming for clinicians.

Clinical Value

LINQ II Insertable Cardiac Monitor

The LINQ II demonstrates strong clinical value through its AccuRhythmu2122 AI algorithms, which provide enhanced accuracy in diagnosing arrhythmias and significantly reduce false alerts, saving valuable clinic time. Clinical studies, such as DEFINE AFib, validate its effectiveness in detecting AF episodes and risk-stratifying patients, with a clear impact on patient management.

Pricing & Value

Vivid T9/Vivid T8

Tool B, the Vivid T9/T8, offers greater pricing transparency with a publicly stated starting price for the Vivid T8 around $22,800 and includes a 3-year service coverage, providing a clearer upfront value proposition. While Tool A's enterprise pricing is not disclosed, Tool B's transparent pricing and included service package give it an edge in this dimension.

Enterprise Readiness

Tie

Both tools exhibit strong enterprise readiness tailored to their respective domains. Tool A offers hybrid deployment, HIPAA compliance, FDA clearance, and an established CareLink network for remote patient management, supporting over a million patients. Tool B provides on-premise hardware, supports HIPAA compliance, is FDA cleared, and features DICOM connectivity and integration with comprehensive imaging and reporting ecosystems like EchoPACu2122 and ViewPoint EchoPilotu2122.

Innovation

LINQ II Insertable Cardiac Monitor

Tool A, the LINQ II, showcases significant innovation with its AccuRhythmu2122 AI algorithms that dramatically reduce false alerts in an implantable cardiac monitor, improving diagnostic accuracy and clinician efficiency. Its remote programming capability for an implanted device also represents a notable advancement in patient care and device management.

Support & Docs

Tie

Both companies provide comprehensive support and documentation. Medtronic (Tool A) offers 24-hour technical support, educational resources, and dedicated patient support services. GE HealthCare (Tool B) provides extensive service and user manuals, application support, and advanced remote service capabilities via InSiteu2122 ExC.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Vivid T9/Vivid T8
Product Type Insertable Cardiac Monitor Cardiovascular Ultrasound Systems
Company Medtronic GE HealthCare
Key AI-Powered Features AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Innovative PVC detection algorithm AI-based Cardiac Auto Doppler for automated measurements, AutoEF (Automated Ejection Fraction), Automated Function Imaging (AFI)
Specialties Cardiology Cardiology, Critical Care, Radiology
Mobile App Support both (MyCareLink Heartu2122 mobile app) Not specified
Customer Count / Scale More than 1 million patients have received a Medtronic ICM worldwide Not specified

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Vivid T9/Vivid T8.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and diagnosing arrhythmias. In contrast, the GE HealthCare Vivid T9/T8 are advanced cardiovascular ultrasound systems primarily used for enhanced imaging, workflow, and diagnostics across various medical specialties.
The LINQ II utilizes AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting and classifying arrhythmias, including innovative PVC detection, and reducing false alerts, which can save clinicians significant review time. The Vivid T9/T8 systems feature AI-powered tools like Cardiac Auto Doppler, AutoEF, Automated Function Imaging (AFI), and AI Auto Measure for automated measurements, and Scan Assist Pro for optimized workflow efficiency and standardized exam procedures.
The LINQ II transmits data via the MyCareLink Heartu2122 mobile app or the MyCareLink Relayu2122 home communicator, enabling remote programming and continuous data flow to the CareLinku2122 network. The Vivid T9/T8 systems support DICOM connectivity for image and data management, and can integrate with services like Tricefyu00ae Cloud for archiving and sharing, with features like disk encryption for patient data security.
Yes, the Medtronic LINQ II has a pediatric indication for patients aged 2 years and older who have heart rhythm abnormalities and require long-term, continuous monitoring. The provided information for the GE HealthCare Vivid T9/T8 systems does not explicitly state a pediatric indication, though some features like Cardiac Auto Doppler are mentioned as supporting pediatric TTE and TEE studies.
The Medtronic LINQ II provides long-term, continuous heart rhythm monitoring for up to 4.5 years. The GE HealthCare Vivid T9/T8 systems perform point-in-time cardiovascular ultrasound imaging and diagnostics, offering advanced quantitative tools for immediate assessment.
The Medtronic LINQ II is primarily designed for Cardiology, focusing on diagnosing arrhythmias and managing cardiac conditions. The GE HealthCare Vivid T9/T8 systems serve Cardiology, Critical Care, and Radiology, offering shared services capabilities for both cardiac and general imaging.
AI Tool Finder
AI-powered search. Results may not be comprehensive.